Track: Cancer Pharmaceutical

Cancer Pharmaceutical

Examine the latest developments in cancer pharmaceuticals, including novel drugs and targeted therapies. This session will cover the pipeline of new medications, advancements in drug delivery systems, and the challenges of overcoming resistance. Engage with pharmaceutical experts as they discuss the impact of these innovations on treatment paradigms and patient care.

• Drug Development
• Radiopharmaceuticals
• Angiogenesis Inhibitors
• PARP Inhibitors
• Tyrosine Kinase Inhibitors (TKIs)
• Personalized Medicine
• Companion Diagnostics